| Triple-Negative Breast Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived143 of 143show fewer |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 140 trials (76 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 140 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall_molecule 102 trials (52 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 102 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 93 trials (46 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 93 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 70 trials (33 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 58 trials (24 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 45 trials (23 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 45 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 39 trials (18 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall_molecule 33 trials (14 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 32 trials (23 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal_antibody 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall_molecule 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall_molecule 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 20 trials (10 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall_molecule 20 trials (8 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 17 trials (7 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 16 trials (8 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall_molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal_antibody 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 6 trials (6 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall_molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Birabresibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onalespibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 7-Ethyl-10-Hydroxycamptothecinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inavolisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD1 Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PI3Kbeta Inhibitor AZD8186 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pictilisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pidnarulexsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porcupine Inhibitor WNT974 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pyrotinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Seribantumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Uprosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |